{
  "$schema": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/QualificationPlan/v3.3/schemas/OSP_Qualification_Plan_Schema.json",
  "Projects": [
    {
      "Id": "Tizanidine",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Tizanidine-Model/v2.0/Tizanidine-Model.json"
    },
    {
      "Id": "Ethinylestradiol",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Ethinylestradiol-Model/v2.0/Ethinylestradiol-Model.json"
    },
    {
      "Id": "Fluvoxamine",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Model/alt_v1.0/Fluvoxamine-Model.json"
    },
    {
      "Id": "Mexiletine",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Mexiletine-Model/v2.0/Mexiletine-Model.json"
    },
    {
      "Id": "Tizanidine-Ethinylestradiol-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Ethinylestradiol-Tizanidine-DDI/v1.1/Ethinylestradiol-Tizanidine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Tizanidine",
          "Project": "Tizanidine"
        },
        {
          "Type": "Compound",
          "Name": "Ethinylestradiol",
          "Project": "Ethinylestradiol"
        },
        {
          "Type": "Formulation",
          "Name": "Ethinylestradiol tablet",
          "Project": "Ethinylestradiol"
        },
        {
          "Type": "Formulation",
          "Name": "Tizanidine tablet fasted",
          "Project": "Tizanidine"
        }
      ],
      "SimulationParameters": []
    },
    {
      "Id": "Caffeine-Fluvoxamine-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Caffeine-DDI/alt_v1.0/Fluvoxamine-Caffeine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Formulation",
          "Name": "Fluvoxamine tablet",
          "Project": "Fluvoxamine"
        }
      ],
      "SimulationParameters": []
    },
    {
      "Id": "Tizanidine-Fluvoxamine-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Tizanidine-DDI/v1.1/Fluvoxamine-Tizanidine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Compound",
          "Name": "Tizanidine",
          "Project": "Tizanidine"
        },
        {
          "Type": "Formulation",
          "Name": "Fluvoxamine tablet",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Formulation",
          "Name": "Tizanidine tablet fasted",
          "Project": "Tizanidine"
        }
      ],
      "SimulationParameters": []
    },
    {
      "Id": "Caffeine-Mexiletine-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Mexiletine-Caffeine-DDI/v1.1/Mexiletine-Caffeine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Mexiletine",
          "Project": "Mexiletine"
        },
        {
          "Type": "Formulation",
          "Name": "Mexiletine tablet",
          "Project": "Mexiletine"
        }
      ],
      "SimulationParameters": []
    },
    {
      "Id": "Tizanidine-Mexiletine-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Mexiletine-Tizanidine-DDI/v1.1/Mexiletine-Tizanidine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Mexiletine",
          "Project": "Mexiletine"
        },
        {
          "Type": "Compound",
          "Name": "Tizanidine",
          "Project": "Tizanidine"
        },
        {
          "Type": "Formulation",
          "Name": "Mexiletine tablet",
          "Project": "Mexiletine"
        },
        {
          "Type": "Formulation",
          "Name": "Tizanidine tablet fasted",
          "Project": "Tizanidine"
        },
        {
          "Type": "Formulation",
          "Name": "Tizanidine tablet fed",
          "Project": "Tizanidine"
        }
      ],
      "SimulationParameters": []
    },
    {
      "Id": "Mexiletine-Fluvoxamine-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Mexiletine-DDI/v1.1/Fluvoxamine-Mexiletine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Mexiletine",
          "Project": "Mexiletine"
        },
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Formulation",
          "Name": "Mexiletine tablet",
          "Project": "Mexiletine"
        },
        {
          "Type": "Formulation",
          "Name": "Fluvoxamine tablet",
          "Project": "Fluvoxamine"
        }
      ],
      "SimulationParameters": []
    },
    {
      "Id": "Caffeine-Ethinylestradiol-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Ethinylestradiol-Caffeine-DDI/v1.1/Ethinylestradiol-Caffeine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Ethinylestradiol",
          "Project": "Ethinylestradiol"
        },
        {
          "Type": "Formulation",
          "Name": "Ethinylestradiol tablet",
          "Project": "Ethinylestradiol"
        }
      ],
      "SimulationParameters": []
    }
  ],
  "ObservedDataSets": [
    {
      "Id": "DDI Ratios",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Database-for-observed-data/v1.7/DDI.csv",
      "Type": "DDIRatio"
    }
  ],
  "Plots": {
    "AxesSettings": {
      "GOFMergedPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "GOFMergedPlotsResidualsOverTime": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Linear"
        }
      ],
      "ComparisonTimeProfile": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsResidualsVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "PKRatioPlots": [
        {
          "Type": "X",
          "Dimension": "Age",
          "Unit": "year(s)",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ]
    },
    "PlotSettings": {
      "ChartWidth": 500,
      "ChartHeight": 400,
      "Fonts": {
        "AxisSize": 11,
        "LegendSize": 9,
        "OriginSize": 9,
        "FontFamilyName": "Arial",
        "WatermarkSize": 40
      }
    },
    "AllPlots": [],
    "GOFMergedPlots": [],
    "ComparisonTimeProfilePlots": [
      {
        "SectionReference": "ct-profiles-tizanidine-ethinylestradiol-ddi",
        "Title": "Granfors 2005 (Tizanidine 4 mg po)",
        "SimulationDuration": 492,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Tizanidine-Ethinylestradiol-DDI",
            "Simulation": "Tizanidine 4mg po",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Tizanidine.Granfors2005.4.po.without EE",
            "StartTime": 480,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Ethinylestradiol)",
            "Symbol": "Circle"
          },
          {
            "Project": "Tizanidine-Ethinylestradiol-DDI",
            "Simulation": "Tizanidine 4mg po Ethinylestradiol 20mg po",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Tizanidine.Granfors2005.4.po.with EE",
            "StartTime": 480,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Ethinylestradiol",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "ct-profiles-caffeine-fluvoxamine-ddi",
        "Title": "Jeppesen 1996 (Caffeine 200 mg po)",
        "SimulationDuration": 290,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Caffeine-Fluvoxamine-DDI",
            "Simulation": "Caffeine 200mg po",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Jeppesen1996.Caffeine.200.po.day8.No_Fluvox",
            "StartTime": 168,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Caffeine-Fluvoxamine-DDI",
            "Simulation": "Caffeine 200mg po 400g Fluvox",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Jeppesen1996.Caffeine.200.po.day8.With_Fluvox",
            "StartTime": 168,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "ct-profiles-caffeine-fluvoxamine-ddi",
        "Title": "Culm-Merdeck 2005 (Caffeine 250 mg po)",
        "SimulationDuration": 50,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Caffeine-Fluvoxamine-DDI",
            "Simulation": "Caffeine 250mg po",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Culm-Merdeck2005.Caffeine.250.po.No_Fluvox",
            "StartTime": 25,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Caffeine-Fluvoxamine-DDI",
            "Simulation": "Caffeine 250mg 120mg predose po100mg Fluvox",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "CulmMerdek2005_250mgSD_NA_NA_Caffeine_DDI",
            "StartTime": 25,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "ct-profiles-tizanidine-fluvoxamine-ddi",
        "Title": "Granfors 2004 (Tizanidine 4 mg po)",
        "SimulationDuration": 98,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Tizanidine-Fluvoxamine-DDI",
            "Simulation": "Tizanidine 4mg po",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Granfors2004.Tizanidine.4mg.po.sd.Tab_fasted.control.DAY4",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Tizanidine-Fluvoxamine-DDI",
            "Simulation": "Tizanidine 4mg po Fluvoxamine 100mg",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Granfors2004.Tizanidine.4mg.po.sd.Tab_fasted.withFluvoxamine_DAY4",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "ct-profiles-tizanidine-mexiletine-ddi",
        "Title": "Momo 2010 (Tizanidine 2 mg po)",
        "SimulationDuration": 30,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Tizanidine-Mexiletine-DDI",
            "Simulation": "Tizanidine 2mg po",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Momo2010.Tizanidine.m.2.po.control",
            "StartTime": 24,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Mexiletine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Tizanidine-Mexiletine-DDI",
            "Simulation": "Tizanidine 2mg po Mexiletine 50mg",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Momo2010.Tizanidine.m.2.po.withMexiletine",
            "StartTime": 24,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Mexiletine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "ct-profiles-caffeine-mexiletine-ddi",
        "Title": "Joeres 1987 (Caffeine 336 mg po)",
        "SimulationDuration": 25,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Caffeine-Mexiletine-DDI",
            "Simulation": "Caffeine 366mg po",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Joeres1987.Caffeine.366.po",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Mexiletine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Caffeine-Mexiletine-DDI",
            "Simulation": "Caffeine 366mg po Mexiletine 200mg",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Joeres1987.Caffeine+Mexiletine.366.po",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Mexiletine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionReference": "ct-profiles-mexiletine-fluvoxamine-ddi",
        "Title": "Kusumoto 2001 (Mexiletine 166.62 mg po)",
        "SimulationDuration": 193,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Mexiletine-Fluvoxamine-DDI",
            "Simulation": "Mexiletine 166.62 mg po",
            "Output": "Organism|PeripheralVenousBlood|Mexiletine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kusumoto2001.Mexiletine.m.166.62.po",
            "StartTime": 168,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Mexiletine-Fluvoxamine-DDI",
            "Simulation": "Mexiletine 166.62 mg po Fluvoxamine 50mg bid",
            "Output": "Organism|PeripheralVenousBlood|Mexiletine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kusumoto2001.Mexiletine+Fluvoxamine.m.166.62.po",
            "StartTime": 168,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      }
    ],
    "DDIRatioPlots": [
      {
        "SectionReference": "qualification-cyp1a2-ddi",
        "Title": "CYP1A2 DDI",
        "PKParameters": [
          "AUC",
          "CMAX"
        ],
        "PlotTypes": [
          "predictedVsObserved",
          "residualsVsObserved"
        ],
        "Artifacts": [
          "Plot",
          "GMFE",
          "Measure",
          "Table"
        ],
        "Subunits": [
          "Perpetrator",
          "Victim"
        ],
        "Groups": [
          {
            "Caption": "Tizanidine + Ethinylestradiol",
            "Color": "#FF0000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordReference": 14002,
                "SimulationControl": {
                  "Project": "Tizanidine-Ethinylestradiol-DDI",
                  "Simulation": "Tizanidine 4mg po",
                  "StartTime": 480,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Tizanidine-Ethinylestradiol-DDI",
                  "Simulation": "Tizanidine 4mg po Ethinylestradiol 20mg po",
                  "StartTime": 480,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Caffeine + Fluvoxamine",
            "Color": "#008000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordReference": 14004,
                "SimulationControl": {
                  "Project": "Caffeine-Fluvoxamine-DDI",
                  "Simulation": "Caffeine 200mg po",
                  "StartTime": 168,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Caffeine-Fluvoxamine-DDI",
                  "Simulation": "Caffeine 200mg po 400g Fluvox",
                  "StartTime": 168,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordReference": 14006,
                "SimulationControl": {
                  "Project": "Caffeine-Fluvoxamine-DDI",
                  "Simulation": "Caffeine 250mg po",
                  "StartTime": 25,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Caffeine-Fluvoxamine-DDI",
                  "Simulation": "Caffeine 250mg 120mg predose po100mg Fluvox",
                  "StartTime": 25,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Tizanidine + Fluvoxamine",
            "Color": "#0000FF",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordReference": 13017,
                "SimulationControl": {
                  "Project": "Tizanidine-Fluvoxamine-DDI",
                  "Simulation": "Tizanidine 4mg po",
                  "StartTime": 73,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Tizanidine-Fluvoxamine-DDI",
                  "Simulation": "Tizanidine 4mg po Fluvoxamine 100mg",
                  "StartTime": 73,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Caffeine + Mexiletine",
            "Color": "#00C0C0",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordReference": 14008,
                "SimulationControl": {
                  "Project": "Caffeine-Mexiletine-DDI",
                  "Simulation": "Caffeine 366mg po",
                  "StartTime": 0,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Caffeine-Mexiletine-DDI",
                  "Simulation": "Caffeine 366mg po Mexiletine 200mg",
                  "StartTime": 0,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Tizanidine + Mexiletine",
            "Color": "#FF00FF",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordReference": 13018,
                "SimulationControl": {
                  "Project": "Tizanidine-Mexiletine-DDI",
                  "Simulation": "Tizanidine 2mg po",
                  "StartTime": 24,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Tizanidine-Mexiletine-DDI",
                  "Simulation": "Tizanidine 2mg po Mexiletine 50mg",
                  "StartTime": 24,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Mexiletine + Fluvoxamine",
            "Color": "#003300",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Mexiletine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordReference": 14010,
                "SimulationControl": {
                  "Project": "Mexiletine-Fluvoxamine-DDI",
                  "Simulation": "Mexiletine 166.62 mg po",
                  "StartTime": 168,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Mexiletine-Fluvoxamine-DDI",
                  "Simulation": "Mexiletine 166.62 mg po Fluvoxamine 50mg bid",
                  "StartTime": 168,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Caffeine + Ethinylestradiol",
            "Color": "#b2182b",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordReference": 6110,
                "SimulationControl": {
                  "Project": "Caffeine-Ethinylestradiol-DDI",
                  "Simulation": "Caffeine 200mg po",
                  "StartTime": 480,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Caffeine-Ethinylestradiol-DDI",
                  "Simulation": "Caffeine 200mg po Ethinylestradiol 0.03mg po",
                  "StartTime": 480,
                  "TimeUnit": "h"
                }
              }
            ]
          }
        ]
      }
    ]
  },
  "Inputs": [],
  "Sections": [
    {
      "Reference": "introduction",
      "Title": "Introduction",
      "Sections": [
        {
          "Reference": "objective",
          "Title": "Objective",
          "Content": "Content/Qualification_objective.md"
        },
        {
          "Reference": "cyp1a2-ddi-network",
          "Title": "CYP1A2 DDI Network",
          "Content": "Content/Qualification_DDI_network_description.md",
          "Sections": [
            {
              "Reference": "caffeine-ethinylestradiol-ddI",
              "Title": "Caffeine - Ethinylestradiol DDI",
              "Content": "Content/Caffeine-Ethinylestradiol-DDI.md"
            },
            {
              "Reference": "tizanidine-ethinylestradiol-ddi",
              "Title": "Tizanidine - Ethinylestradiol DDI",
              "Content": "Content/Tizanidine-Ethinylestradiol-DDI.md"
            },
            {
              "Reference": "caffeine-fluvoxamine-ddi",
              "Title": "Caffeine - Fluvoxamine DDI",
              "Content": "Content/Caffeine-Fluvoxamine-DDI.md"
            },
            {
              "Reference": "tizanidine-fluvoxamine-ddi",
              "Title": "Tizanidine - Fluvoxamine DDI",
              "Content": "Content/Tizanidine-Fluvoxamine-DDI.md"
            },
            {
              "Reference": "tizanidine-mexiletine-ddi",
              "Title": "Tizanidine - Mexiletine DDI",
              "Content": "Content/Tizanidine-Mexiletine-DDI.md"
            },
            {
              "Reference": "caffeine-mexiletine-ddi",
              "Title": "Caffeine - Mexiletine DDI",
              "Content": "Content/Caffeine-Mexiletine-DDI.md"
            },
            {
              "Reference": "mexiletine-fluvoxamine-ddi",
              "Title": "Mexiletine - Fluvoxamine DDI",
              "Content": "Content/Mexiletine-Fluvoxamine-DDI.md"
            }
          ]
        }
      ]
    },
    {
      "Reference": "qualification-cyp1a2-ddi",
      "Title": "Qualification of Use Case CYP1A2-mediated DDI",
      "Content": "Content/Intro_evaluation_DDI_network.md"
    },
    {
      "Reference": "ct-profiles",
      "Title": "Concentration-Time Profiles",
      "Content": "Content/Intro_evaluation_CTprofiles.md",
      "Sections": [
        {
          "Reference": "ct-profiles-tizanidine-ethinylestradiol-ddi",
          "Title": "Tizanidine - Ethinylestradiol DDI"
        },
        {
          "Reference": "ct-profiles-caffeine-fluvoxamine-ddi",
          "Title": "Caffeine - Fluvoxamine DDI"
        },
        {
          "Reference": "ct-profiles-tizanidine-fluvoxamine-ddi",
          "Title": "Tizanidine - Fluvoxamine DDI"
        },
        {
          "Reference": "ct-profiles-tizanidine-mexiletine-ddi",
          "Title": "Tizanidine - Mexiletine DDI"
        },
        {
          "Reference": "ct-profiles-caffeine-mexiletine-ddi",
          "Title": "Caffeine - Mexiletine DDI"
        },
        {
          "Reference": "ct-profiles-mexiletine-fluvoxamine-ddi",
          "Title": "Mexiletine - Fluvoxamine DDI"
        }
      ]
    },
    {
      "Reference": "conclusion",
      "Title": "Conclusion",
      "Content": "Content/Section4_Conclusion.md",
      "Sections": []
    },
    {
      "Reference": "main-references",
      "Title": "References",
      "Content": "Content/References.md",
      "Sections": []
    },
    {
      "Reference": "appendix",
      "Title": "Appendix",
      "Sections": [
        {
          "Reference": "osp-introduction",
          "Title": "Open Systems Pharmacology Suite (OSPS) Introduction",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.3/OSPS_Introduction.md"
        },
        {
          "Reference": "ddi-implementation",
          "Title": "Mathematical Implementation of Drug-Drug Interactions",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.3/Mathematical_Implementation_of_DDI.md"
        },
        {
          "Reference": "requalification-workflow",
          "Title": "Automatic (re)-qualification workflow",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.3/Qualification_Workflow.md"
        }
      ]
    },
    {
      "Reference": "glossary",
      "Title": "Glossary",
      "Content": "Content/glossary.md"
    }
  ],
  "Intro": [
    {
      "Path": "Content/titlepage.md"
    }
  ]
}